{"product_id":"marubi-soar-analysis","title":"Guangdong Marubi Biotechnology SOAR Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-List-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDive Deeper Into the Growth Paths Behind the Analysis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThis Guangdong Marubi Biotechnology SOAR Analysis helps you quickly understand the company’s strengths, opportunities, aspirations, and results in a clear strategic framework. This page already shows a real preview of the actual report content, so you can review the sample before buying. Purchase the full version to get the complete ready-to-use analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Strengths-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDominant Market Share in Chinese Eye Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGuangdong Marubi holds a leading position in Chinese eye care, with over 15% of the local eye cream market as of early 2026. Two decades of focus let Marubi price its flagship products at 400 to 600 RMB and keep 65% of core customers each year. That dominance gives the Company a steady cash base for expansion into makeup and medical aesthetics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Strengths-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary Recombinant Collagen Technology\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGuangdong Marubi Biotechnology has built a real moat with recombinant collagen and biological fermentation, supported by more than 350 authorized patents and steady R\u0026amp;D spend at about 3.5% of revenue. That five-year push helped it shift from marketing-led to research-led, making scientific skincare harder to copy and less prone to commoditization. The payoff shows up in premium launches, including the luxury anti-aging line that grew about 40%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Strengths-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSuccessful Omnichannel E-commerce Transformation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGuangdong Marubi Biotechnology’s biggest strength is its fast shift from department stores to social commerce, with Douyin sales reaching 30% of total revenue by early 2026. Its live-streaming setup runs 16 hours a day across multiple sub-brands, giving it reach and speed that many rivals lack. Since 2022, this pivot has cut reliance on physical foot traffic by nearly 50% and helped keep inventory turnover about 20 days faster than the industry average.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Strengths-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiverse Portfolio Targeting Multi-Generational Demographics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGuangdong Marubi Biotechnology's multi-brand portfolio spans age and income groups, with Passional Lover for trend-led makeup and Chunji for mass-market skincare. That breadth helps shield the parent company from swings in any one segment, while the flagship brand keeps older buyers engaged. Passional Lover's 25% Gen Z adoption rise after its 2025 \"Modern Noir\" launch shows clear youth pull.\u003c\/p\u003e\n\u003cp\u003eWith a 3,000-point distribution network, Guangdong Marubi Biotechnology can push each brand to the right shopper fast.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Strengths-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHighly Integrated Supply Chain and Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGuangdong Marubi Biotechnology's Industrial Park centralizes production, which helps it keep quality tight and hit a 98% on-time fulfillment rate across mainland China. Owning manufacturing also cuts cost of goods sold by about 12% versus outsourced brands, giving Marubi more room to protect margins. In 2025, that vertical control helped it absorb raw material swings, hold retail prices steady, and launch new items in as little as 45 days.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Strengths-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarubi's Eye Care Moat Stays Strong with Patents, Retention and Douyin Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIn 2025, Guangdong Marubi Biotechnology kept a strong moat in eye care, with over 15% local market share and 65% annual retention of core customers. Its premium eye cream line sold at 400 to 600 RMB, supporting stable cash flow.\u003c\/p\u003e\n\u003cp\u003eR\u0026amp;D is another strength: more than 350 patents and about 3.5% of revenue spent on research helped build recombinant collagen and fermentation expertise.\u003c\/p\u003e\n\u003cp\u003eChannel shift also helped, with Douyin reaching 30% of revenue in early 2026 and a 98% on-time fulfillment rate from its industrial park.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eEye cream share\u003c\/td\u003e\n\u003ctd\u003e15%+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatents\u003c\/td\u003e\n\u003ctd\u003e350+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCore retention\u003c\/td\u003e\n\u003ctd\u003e65%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\nProvides a clear SOAR framework for analyzing Guangdong Marubi Biotechnology’s strategic development potential\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eEditable Excel File\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\nHelps Guangdong Marubi Biotechnology quickly pinpoint strengths, opportunities, aspirations, and results in one clear view.\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eO\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003epportunities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Opportunities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExpansion into the Professional Medical Aesthetics Channel\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn China, post-procedure skincare is expanding fast, with the medical repair market projected to grow about 22% a year, creating a strong opening for Guangdong Marubi Biotechnology. Less than 5% of Marubi revenue still comes from clinical channels, so even modest gains in dermatology partnerships could add high-margin sales. Clinical-grade products for laser and peel recovery also fit Marubi’s collagen patents, and trust is highest in this channel.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Opportunities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHyper-Personalization via AI Skin Diagnostics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAI skin diagnostics could lift Guangdong Marubi Biotechnology's average basket by linking scan results to serum, cream, and sunscreen bundles in-store and in-app. China's online beauty market topped 500 billion yuan in 2025, so a proprietary skin-profile base could sharpen targeting and cut customer acquisition costs by up to 15%. If Marubi reaches 5 million profiles by 2026, it can turn one-off buys into repeat, data-led skincare plans.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Opportunities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Opportunities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUntapped Growth in Tier 3 and 4 Cities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTier 3 and 4 cities are a real opening for Guangdong Marubi Biotechnology, as lower-tier China consumption is still rising about 8% a year and shoppers are trading up from cheap local brands.\u003c\/p\u003e\n\u003cp\u003eMarubi’s heritage brand can win these aspirational buyers, while mini-stores in regional malls add the kind of local touchpoint global luxury rivals often skip.\u003c\/p\u003e\n\u003cp\u003eEarly 2026 pilots already showed 20% higher conversion in Tier 3 cities than in Tier 1 metros.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Opportunities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eThe Evolution of the Global 'Guochao' Trend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eChina Pride is giving Marubi a cleaner shot at share gains as domestic buyers favor brands tied to Asian skin science and local identity. Marubi can sharpen its Eastern Tech message to deepen loyalty and pull spend from foreign rivals. If the expected 3.5 billion USD shift in beauty spend lands over the next two years, Marubi is well placed to capture a larger slice.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Opportunities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Expansion into Southeast Asian E-commerce\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSoutheast Asia gives Guangdong Marubi Biotechnology a nearby, low-capex entry path through Shopee and Lazada, so it can test Thailand and Vietnam without heavy store buildout. Hot, humid climates and common hydration and eye-care needs make Marubi's product mix a strong fit, and taking just 1% of a 10 billion RMB regional niche would add about 100 million RMB in annual sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Opportunities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarubi’s Growth Engines: Clinical Skincare, AI Bundles, and SEA Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGuangdong Marubi Biotechnology’s best openings are clinical skincare, AI-led bundles, lower-tier city expansion, and Southeast Asia. China’s post-procedure repair market is growing about 22% a year, while online beauty sales topped 500 billion yuan in 2025, giving Marubi room to lift high-margin sales and repeat buys.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eOpportunity\u003c\/th\u003e\n\u003cth\u003e2025 signal\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinical repair\u003c\/td\u003e\n\u003ctd\u003e22% growth\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOnline beauty\u003c\/td\u003e\n\u003ctd\u003e500b yuan\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTier 3-4 cities\u003c\/td\u003e\n\u003ctd\u003e8% growth\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eGuangdong Marubi Biotechnology Reference Sources\u003c\/h2\u003e\n\u003cp\u003eThis is the actual Guangdong Marubi Biotechnology SOAR analysis document you’ll receive after purchase—no placeholders or sample text. The preview below is pulled directly from the full report, so what you see here is the same professional, structured file you’ll download. Unlock the complete version after checkout for full details.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview-Image.png\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003espirations\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Aspirations-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBecoming the Top Luxury Cosmetic Powerhouse in Asia\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGuangdong Marubi Biotechnology wants to move beyond a domestic-brand label and stand beside French and American luxury houses on prime mall shelves. Its goal is clear: build stronger brand equity and win a true prestige position in Asia.\u003c\/p\u003e\n\u003cp\u003eThe company is also targeting a 10% average price increase every two years, using tech-led product upgrades to support higher pricing power. That kind of premiumization can lift margins if consumers keep trading up.\u003c\/p\u003e\n\u003cp\u003eIf Marubi delivers, it could sit at the center of Asia's beauty premiumization, where luxury demand still rewards brands with strong science, image, and repeat purchase power.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Aspirations-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAchieving 100 Percent Carbon Neutrality in Production\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGuangdong Marubi Biotechnology aims to turn its Biotechnology Industrial Park into a green-energy benchmark by 2030, with 100% sustainable packaging across all product lines and a 40% cut in emissions per unit produced by 2028. That matters because ESG-linked capital keeps rising, and institutional investors now screen for measurable decarbonization, not slogans. In cosmetics, where packaging waste is a major issue, Marubi can stand out by tying lower carbon intensity to real operating discipline.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Aspirations-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Aspirations-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLeading the World in Recombinant Collagen Application\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGuangdong Marubi Biotechnology wants to move from skincare into bio-manufacturing, with recombinant collagen as a core bioactive ingredient. Its aim is to become a global supplier to cosmetic and medical users, backed by international certifications. In 2025, it targets 20% of B2B revenue from patent licensing, but no public 2025 filing showed that share yet.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Aspirations-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePerfecting the Digitally Integrated Retail Experience\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGuangdong Marubi Biotechnology aims for a borderless retail model where store visits and online fulfillment feel like one journey. The 85% conversion target for physical-store visitors into high-value digital loyalty members would give the Company a much richer first-party data base to lift repeat purchase rates and lifetime value. Smart mirrors and 5G-linked inventory access can then give shoppers instant, personalized product and stock information at the shelf, cutting friction and speeding purchase decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Aspirations-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRedefining Beauty Standards for the Gen Z Market\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThrough Passional Lover and other sub-brands, Guangdong Marubi Biotechnology is aiming to become the leading youth makeup voice in East Asia, with a stated goal of No. 1 domestic youth-makeup market share by 2027. To get there, it must keep a steady stream of creator collaborations and make shopping feel like play, since Gen Z buys heavily through short video and social commerce. If it wins this cohort now, the brand can anchor demand for the next generation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Aspirations-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarubi Bets on Premiumization, ESG, and Bio-Based Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGuangdong Marubi Biotechnology's aspirations center on premiumization, ESG, and bio-based expansion. It wants a 10% price lift every two years, 100% sustainable packaging by 2030, and a 40% cut in emissions per unit by 2028. It also aims to grow recombinant collagen into a global B2B bioactive business and lift youth makeup share in East Asia.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eGoal\u003c\/th\u003e\n\u003cth\u003eTarget\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrice increase\u003c\/td\u003e\n\u003ctd\u003e10% every 2 years\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSustainable packaging\u003c\/td\u003e\n\u003ctd\u003e100% by 2030\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmissions per unit\u003c\/td\u003e\n\u003ctd\u003e40% cut by 2028\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYouth makeup share\u003c\/td\u003e\n\u003ctd\u003eNo. 1 in China by 2027\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesults\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Results-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRecord Revenue Performance in the 2025 Fiscal Year\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGuangdong Marubi Biotechnology closed fiscal 2025 with revenue above RMB 2.3 billion, up 14% year over year, showing its e-commerce shift is working.\u003c\/p\u003e\n\u003cp\u003eGross margin held near 68%, which means growth did not come from discounting away profit.\u003c\/p\u003e\n\u003cp\u003eThat mix of higher sales and stable margins leaves Marubi with solid cash generation for its 2026 expansion plans.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Results-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExplosive Growth on Social Commerce Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBy March 2026, Guangdong Marubi Biotechnology reported a 120% jump in gross merchandise value on TikTok-style social commerce versus 2024 benchmarks. During peak 11.11 festival periods, its live-streaming rooms drew more than 100,000 concurrent viewers, showing strong conversion power in direct-to-consumer sales. This shift cut third-party retail commissions and helped lift net income, supporting the return on its RMB 50 million studio buildout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Results-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Results-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eScientific Skincare Portfolio Surpasses Sales Targets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGuangdong Marubi Biotechnology's \"scientific skincare\" pitch is working: the 3rd Generation Elastic Protein Eye Cream sold over 1.2 million units in its first 12 months. Nearly 45% of buyers were new to the brand, showing strong customer acquisition and fit with technical-minded consumers. This product win supports the company's multi-year investment in proprietary collagen research and helps validate its premium, science-led portfolio.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Results-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOptimized Supply Chain Through Digital Transformation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIn 2025, Guangdong Marubi Biotechnology's AI-driven logistics cut overall supply chain costs by 18%, showing a clear backend gain from digital transformation. Inventory write-offs fell to 2% of total stock, down from 5% in the prior cycle, which improved cash retention and reduced waste. The 40 million RMB surplus shifted into new R\u0026amp;D lab equipment, linking supply chain efficiency directly to product innovation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Results-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSignificant Milestone in Brand Premiumization Efforts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAverage transaction value at flagship counters climbed from 350 RMB in 2024 to 420 RMB by early 2026, a 20% rise that signals stronger premium positioning. Marubi now scores 15 points higher in quality trust than its nearest domestic rival, which supports brand equity and reduces exposure to price cuts in the mass market. This premiumization helps defend margins while shifting demand toward higher-value purchases.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SOAR-Content-Results-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarubi’s FY2025: 14% Revenue Growth, 68% Gross Margin, and AI Efficiency Gains\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFiscal 2025 showed strong results for Guangdong Marubi Biotechnology: revenue topped RMB 2.3 billion, up 14%, while gross margin stayed near 68%. Social commerce GMV rose 120% versus 2024, and the 3rd Generation Elastic Protein Eye Cream sold over 1.2 million units in its first 12 months. AI-led logistics cut supply chain costs 18% and lifted inventory write-offs to 2% of stock, improving cash flow for 2026 growth.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eFY2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eRMB 2.3B+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e~68%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSocial GMV growth\u003c\/td\u003e\n\u003ctd\u003e120%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupply chain cost cut\u003c\/td\u003e\n\u003ctd\u003e18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"SOAR Analysis","offers":[{"title":"Default Title","offer_id":52938782081371,"sku":"marubi-soar-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/6857\/8907\/files\/marubi-soar-analysis.webp?v=1778323506","url":"https:\/\/soar-analysis.com\/products\/marubi-soar-analysis","provider":"SOAR Analysis","version":"1.0","type":"link"}